GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genexine Inc (XKRX:095700) » Definitions » E10

Genexine (XKRX:095700) E10 : ₩0.00 (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Genexine E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Genexine's adjusted earnings per share data for the three months ended in Dec. 2024 was ₩-589.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₩0.00 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Genexine was -10.30% per year. The lowest was -21.20% per year. And the median was -15.75% per year.

As of today (2025-04-04), Genexine's current stock price is ₩3790.00. Genexine's E10 for the quarter that ended in Dec. 2024 was ₩0.00. Genexine's Shiller PE Ratio of today is .


Genexine E10 Historical Data

The historical data trend for Genexine's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genexine E10 Chart

Genexine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -526.70 -620.69 -803.98 -938.40 -

Genexine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -938.40 -968.54 - - -

Competitive Comparison of Genexine's E10

For the Biotechnology subindustry, Genexine's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genexine's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genexine's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Genexine's Shiller PE Ratio falls into.


;
;

Genexine E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Genexine's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-589/121.1352*121.1352
=-589.000

Current CPI (Dec. 2024) = 121.1352.

Genexine Quarterly Data

per share eps CPI Adj_EPS
201503 23.349 99.721 28.363
201506 56.038 100.051 67.847
201509 -452.977 100.111 -548.107
201512 298.153 100.220 360.374
201603 -200.445 100.561 -241.455
201606 -321.861 100.791 -386.828
201609 -273.007 101.461 -325.945
201612 -533.189 101.561 -635.950
201703 -450.462 102.851 -530.544
201706 -589.839 102.611 -696.320
201709 -39.514 103.491 -46.251
201712 311.803 102.991 366.735
201803 -397.297 104.101 -462.308
201806 -160.212 104.130 -186.375
201809 -580.500 105.651 -665.581
201812 -65.378 104.351 -75.894
201903 916.730 104.491 1,062.755
201906 -749.333 104.881 -865.464
201909 -308.211 105.200 -354.896
201912 -535.238 105.121 -616.775
202003 -451.181 105.354 -518.763
202006 -227.027 105.112 -261.635
202009 796.032 106.198 908.001
202012 456.044 105.765 522.316
202103 618.577 107.357 697.964
202106 -579.781 107.579 -652.843
202109 -468.423 108.759 -521.726
202112 -940.438 109.676 -1,038.693
202203 470.578 111.848 509.652
202206 -435.375 114.072 -462.332
202209 -536.675 114.715 -566.709
202212 -1,173.647 115.179 -1,234.337
202303 -665.000 116.507 -691.415
202306 -603.000 117.182 -623.342
202309 -504.000 118.964 -513.200
202312 76.000 118.837 77.470
202403 -279.000 120.123 -281.350
202406 -292.000 120.007 -294.744
202409 -351.000 120.861 -351.796
202412 -589.000 121.135 -589.000

Add all the adjusted EPS together and divide 10 will get our e10.


Genexine  (XKRX:095700) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Genexine E10 Related Terms

Thank you for viewing the detailed overview of Genexine's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Genexine Business Description

Traded in Other Exchanges
N/A
Address
700 Daewangpangyo-ro, Gyeonggi-do, Korea Bio Park Building B, Bundang-gu, Seongnam-si, KOR, 13488
Genexine Inc is a clinical-stage biotechnology company. It is focused on the development and commercialization of immunotherapeutics and next-generation long-acting biologics. Its primary technologies are Therapeutic DNA vaccine technology and Hyfc platform. The company's product pipeline includes products such as GX-H9, GX-E2, GX-G3, GX-G6, and Papitrol-188 among others.

Genexine Headlines

No Headlines